These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 9544525)
1. Sample size calculations based on slopes and other summary statistics. Dawson JD Biometrics; 1998 Mar; 54(1):323-30. PubMed ID: 9544525 [TBL] [Abstract][Full Text] [Related]
2. Sample size determination for constrained longitudinal data analysis. Lu K; Mehrotra DV; Liu G Stat Med; 2009 Feb; 28(4):679-99. PubMed ID: 19051207 [TBL] [Abstract][Full Text] [Related]
3. Group sequential distribution-free methods for the analysis of multivariate observations. Su JQ; Lachin JM Biometrics; 1992 Dec; 48(4):1033-42. PubMed ID: 1290797 [TBL] [Abstract][Full Text] [Related]
4. Marginal analysis of incomplete longitudinal binary data: a cautionary note on LOCF imputation. Cook RJ; Zeng L; Yi GY Biometrics; 2004 Sep; 60(3):820-8. PubMed ID: 15339307 [TBL] [Abstract][Full Text] [Related]
6. Stratified testing for treatment effects with missing data. Shih WJ; Quan H Biometrics; 1998 Jun; 54(2):782-7. PubMed ID: 9660633 [TBL] [Abstract][Full Text] [Related]
7. Design considerations in crossover trials with a single interim analysis and serial patient entry. Cook RJ; Willan AR Biometrics; 1996 Jun; 52(2):732-9. PubMed ID: 8672709 [TBL] [Abstract][Full Text] [Related]
9. Sample size estimation for non-inferiority trials of time-to-event data. Crisp A; Curtis P Pharm Stat; 2008; 7(4):236-44. PubMed ID: 17583558 [TBL] [Abstract][Full Text] [Related]
10. Sample size determination for clinical trials in patients with nonlinear disease progression. Yan X; Su X J Biopharm Stat; 2006; 16(1):91-105. PubMed ID: 16440839 [TBL] [Abstract][Full Text] [Related]
11. Calculation of sample size in survival trials: the impact of informative noncompliance. Jiang Q; Snapinn S; Iglewicz B Biometrics; 2004 Sep; 60(3):800-6. PubMed ID: 15339304 [TBL] [Abstract][Full Text] [Related]
12. Sample size calculation in survival trials accounting for time-varying relationship between noncompliance and risk of outcome event. Li B; Grambsch P Clin Trials; 2006; 3(4):349-59. PubMed ID: 17060209 [TBL] [Abstract][Full Text] [Related]
13. Issues in the selection of a summary statistic for meta-analysis of clinical trials with binary outcomes. Deeks JJ Stat Med; 2002 Jun; 21(11):1575-600. PubMed ID: 12111921 [TBL] [Abstract][Full Text] [Related]
15. Variance estimation in clinical studies with interim sample size re-estimation. Miller F Biometrics; 2005 Jun; 61(2):355-61. PubMed ID: 16011681 [TBL] [Abstract][Full Text] [Related]
16. Sample size calculations in the presence of competing risks. Latouche A; Porcher R Stat Med; 2007 Dec; 26(30):5370-80. PubMed ID: 17955563 [TBL] [Abstract][Full Text] [Related]
17. A SAS macro for sample size adjustment and randomization test for internal pilot study. Wang S; Xia J; Yu L; Li C; Xu L Comput Methods Programs Biomed; 2008 Apr; 90(1):66-88. PubMed ID: 18192069 [TBL] [Abstract][Full Text] [Related]
18. Bayesian sample size calculations for a non-inferiority test of two proportions in clinical trials. Daimon T Contemp Clin Trials; 2008 Jul; 29(4):507-16. PubMed ID: 18201944 [TBL] [Abstract][Full Text] [Related]
19. Estimates, power and sample size calculations for two-sample ordinal outcomes under before-after study designs. Strickland PA; Lu SE Stat Med; 2003 Jun; 22(11):1807-18. PubMed ID: 12754716 [TBL] [Abstract][Full Text] [Related]